Carboxyterminal Telopeptide of Type I Collagen (ICTP) in Predicting Prognosis in Epithelial Ovarian Cancer
- 1 July 2001
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 82 (1) , 110-115
- https://doi.org/10.1006/gyno.2001.6212
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Immunochemical characterization of assay for carboxyterminal telopeptide of human type I collagen: loss of antigenicity by treatment with cathepsin KBone, 2000
- Cross-linked telopeptides of type I and III collagens in malignant ovarian tumours in vivoBritish Journal of Cancer, 1999
- Synthesis and breakdown of fibrillar collagens: concomitant phenomena in ovarian cancerBritish Journal of Cancer, 1998
- CA 125 kinetics: A cost-effective clinical tool to evaluate clinical trial outcomes in the 1990sAmerican Journal of Obstetrics and Gynecology, 1996
- Preoperative CA 125: An Independent Prognostic Factor in Patients With Stage I Epithelial Ovarian CancerObstetrics & Gynecology, 1995
- Elevated Serum ICTP Concentrations Reflect Poor Prognosis in Patients with Ovarian CarcinomaAnnals of Medicine, 1995
- Serum CA 125 Level Allows Early Identification of Nonresponders during Induction ChemotherapyGynecologic Oncology, 1993
- Prognostic value of CA 125 in advanced ovarian cancerGynecologic Oncology, 1992
- The prognostic significance of CA 125 half-life in patients with ovarian cancer who have received primary chemotherapy after surgical cytoreductionAmerican Journal of Obstetrics and Gynecology, 1990
- Ovarian cancer: The prognostic value of the serum half-life of CA125 during induction chemotherapyGynecologic Oncology, 1988